Question

Difficulty: HardDiagnostic Workup and Test Sequencing

A 48-year-old man is evaluated in the clinic for persistently elevated blood pressure. He was diagnosed with hypertension three years ago. His current medications include maximally tolerated doses of amlodipine, lisinopril, and doxazosin. He reports no headaches, palpitations, or diaphoresis. Vital signs are significant for a blood pressure of 168/98 mm Hg and a heart rate of 76/min. Physical examination is unremarkable, and no abdominal bruits are auscultated.

Current laboratory studies:
Sodium: 144 mEq/L
Potassium: 2.8 mEq/L
Chloride: 102 mEq/L
Bicarbonate: 29 mEq/L
Creatinine: 0.9 mg/dL

A review of his medical records indicates that his potassium was 3.1 mEq/L prior to the initiation of any antihypertensive therapy. Due to high clinical suspicion for secondary hypertension, hormonal screening is obtained:

Plasma renin activity (PRA): 0.2 ng/mL/h (Normal: 0.6 - 4.3 ng/mL/h)
Plasma aldosterone concentration (PAC): 28 ng/dL (Normal: 4 - 21 ng/dL)

Which of the following is the most appropriate next step in the diagnostic workup?

  1. Adrenal protocol computed tomographyAnswer
  2. B
    Intravenous saline infusion test
  3. C
    Adrenal venous sampling
  4. D
    24-hour urine collection for fractionated metanephrines
  5. E
    Discontinuation of lisinopril and repeat hormonal screening in two weeks

Answer

The most appropriate next step is to obtain an adrenal protocol computed tomography.
The correct answer is adrenal protocol computed tomography. The standard diagnostic algorithm for primary hyperaldosteronism involves three sequential phases: screening (aldosterone-to-renin ratio), confirmation (e.g., intravenous saline infusion, oral sodium loading), and subtype classification (adrenal CT followed by adrenal venous sampling if indicated). However, clinical guidelines establish a critical exception: patients who present with spontaneous hypokalemia, a suppressed plasma renin activity (or direct renin concentration), and a markedly elevated plasma aldosterone concentration (> 20 ng/dL) have an unequivocally established diagnosis. For these patients, dynamic confirmatory testing is redundant and should be bypassed. The immediate next step is to initiate subtype classification with an adrenal protocol CT to identify adenomas, bilateral hyperplasia, or rare adrenal carcinomas.

Step-by-Step Solution

1
Analyze the clinical presentation and baseline labs.
The patient has resistant hypertension and spontaneous hypokalemia (potassium was 3.1 mEq/L before starting any diuretics or antihypertensives), highly suggestive of primary hyperaldosteronism.
Identifying spontaneous hypokalemia is a critical branch point in the diagnostic algorithm for endocrine hypertension.
2
Interpret the screening hormonal assays.
Plasma renin activity (PRA) is suppressed (0.2 ng/mL/h) and plasma aldosterone concentration (PAC) is markedly elevated (28 ng/dL).
An elevated aldosterone-to-renin ratio (ARR) is the recommended initial screening test for primary hyperaldosteronism.
3
Determine the necessity of confirmatory testing.
The patient meets the strict criteria (spontaneous hypokalemia, PRA < 1.0 ng/mL/h, and PAC > 20 ng/dL) to definitively diagnose primary hyperaldosteronism without dynamic confirmatory testing.
Guidelines explicitly state that confirmatory testing (like an oral sodium load or saline infusion) can be bypassed in unequivocal cases to avoid unnecessary cost and delay.
4
Select the appropriate next sequential step.
Adrenal protocol computed tomography is the next indicated test.
Once the diagnosis is confirmed (biochemically), the next step is subtype classification (distinguishing unilateral adenoma from bilateral hyperplasia), which always begins with adrenal imaging.

Key Concept

In patients with suspected primary hyperaldosteronism, the diagnosis is unequivocally established if they present with the triad of spontaneous hypokalemia, suppressed plasma renin activity, and a plasma aldosterone concentration > 20 ng/dL. These patients should bypass dynamic confirmatory testing and proceed directly to subtype classification with adrenal computed tomography.
Rate this question